Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +1 vs. Q1 2023
- Shares held
- 15.1M
- −89.7K (−0.6%) vs. Q1 2023
- Total value
- $196.0M
- +$4.98M (+2.6%) vs. Q1 2023
- New holders
- 5
- 17 more added
- Sold out
- 4
- 11 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 422 | $5.47K | 0.00% | +300+245.9% | Added |
| Ameritas Investment Partners, Inc. | 695 | $9.01K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 732 | $9.49K | 0.00% | −360−33.0% | Reduced |
| STRS Ohio | 800 | $10.0K | 0.00% | −1,000−55.6% | Reduced |
| Amalgamated Bank | 781 | $10.0K | 0.00% | −349−30.9% | Reduced |
| Legal & General Group Plc | 839 | $10.9K | 0.00% | −85−9.2% | Reduced |
| Royal Bank of Canada | 907 | $12.0K | 0.00% | +242+36.4% | Added |
| New York State Common Retirement Fund | 2,275 | $29.5K | 0.00% | +69+3.1% | Added |
| Citigroup Inc | 2,790 | $36.2K | 0.00% | +2,588+1,281.2% | Added |
| California State Teachers Retirement System | 2,891 | $37.5K | 0.00% | −327−10.2% | Reduced |
| Wells Fargo & Company | 3,305 | $42.8K | 0.00% | +1,717+108.1% | Added |
| Deutsche Bank AG | 4,062 | $52.6K | 0.00% | −1,307−24.3% | Reduced |
| American International Group, Inc. | 4,183 | $54.2K | 0.00% | +5+0.1% | Added |
| JPMorgan Chase & Co | 6,927 | $89.8K | 0.00% | +297+4.5% | Added |
| Bank of America Corp | 7,624 | $98.8K | 0.00% | +1,768+30.2% | Added |
| Morgan Stanley | 8,505 | $110.2K | 0.00% | +2,881+51.2% | Added |
| Rhumbline Advisers | 8,986 | $116.5K | 0.00% | +8,986 | New |
| UBS Group AG | 9,780 | $126.7K | 0.00% | +4,384+81.2% | Added |
| AAFCPAs Wealth Management, LLC | 10,678 | $138.4K | 0.09% | +10,678 | New |
| Exchange Traded Concepts, LLC | 11,709 | $151.7K | 0.00% | +11,709 | New |
| Nuveen Asset Management, LLC | 11,821 | $153.2K | 0.00% | +11,821 | New |
| Barclays PLC | 14,263 | $184.8K | 0.00% | −2,720−16.0% | Reduced |
| Bank of New York Mellon Corp | 24,795 | $321.3K | 0.00% | +1,958+8.6% | Added |
| D. E. Shaw & Co., Inc. | 46,910 | $608.0K | 0.00% | −14,986−24.2% | Reduced |
| Charles Schwab Investment Management Inc | 60,958 | $790.0K | 0.00% | +2,749+4.7% | Added |
| Northern Trust Corp | 68,678 | $890.1K | 0.00% | −1,073−1.5% | Reduced |
| DAFNA Capital Management LLC | 76,852 | $996.0K | 0.27% | +25,704+50.3% | Added |
| UBS Oconnor LLC | 100,000 | $1.30M | 0.03% | +100,000 | New |
| State Street Corp | 125,976 | $1.63M | 0.00% | +40,637+47.6% | Added |
| Geode Capital Management, LLC | 178,453 | $2.31M | 0.00% | +3,049+1.7% | Added |
| Federated Hermes, Inc. | 304,411 | $3.95M | 0.01% | −309,214−50.4% | Reduced |
| Vanguard Group Inc | 403,275 | $5.23M | 0.00% | −5,940−1.5% | Reduced |
| NEA Management Company, LLC | 481,677 | $6.24M | 0.48% | 00.0% | Unchanged |
| BlackRock Inc. | 533,355 | $6.91M | 0.00% | +59,128+12.5% | Added |
| Marshall Wace, LLP | 597,469 | $7.74M | 0.02% | 00.0% | Unchanged |
| Wellington Management Group LLP | 888,130 | $11.5M | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,649,646 | $21.4M | 0.02% | +8,624+0.5% | Added |
| Sands Capital Ventures, LLC | 1,652,605 | $21.4M | 6.34% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $39.0M | 1.13% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,810,508 | $62.3M | 1.18% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,262−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,718−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −5,081−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −523−100.0% | Sold out |